From: The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus
Lipid Characteristics | All Patients | Event1 | No Event2 | P- Value3 | |||
---|---|---|---|---|---|---|---|
N = 72,267 | n = 7,271 | n = 64,996 | |||||
# Days from Last Lipid Panel to Any Microvascular Event/Censorship: mean ± SD | 346.21 | ±351.43 | 148.40 | ±223.94 | 368.34 | ±356.15 | <.0001 |
Lipid Panel Values: mean ± SD | |||||||
LDL-C | 109.08 | ±34.35 | 108.33 | ±36.47 | 109.16 | ±34.1 | .0513 |
HDL-C | 48.02 | ±14.13 | 46.72 | ±14.04 | 48.16 | ±14.13 | <.0001 |
Triglycerides | 163.35 | ±122 | 186.39 | ±186.41 | 160.77 | ±112.23 | <.0001 |
Non-HDL-C | 140.55 | ±40.25 | 143.19 | ±45.9 | 140.26 | ±39.56 | <.0001 |
Lipid Goal Attainment Results: n, row% | |||||||
LDL-C | 30,395 | 42.06 % | 3,185 | 43.80 % | 27,210 | 41.86 % | .0015 |
HDL-C | 37,946 | 52.51 % | 3,527 | 48.51 % | 34,419 | 52.96 % | <.0001 |
Triglycerides | 43,577 | 60.30 % | 3,948 | 54.30 % | 39,629 | 60.97 % | <.0001 |
Non-HDL-C | 30,737 | 42.53 % | 3,032 | 41.70 % | 27,705 | 42.63 % | .1299 |